[Okgrantsmanship] JUST RELEASED! FY13 DOD CDMRP Program Pre-Announcements
Mason, Linda
lmason at osrhe.edu
Tue Jun 4 11:26:10 CDT 2013
Dear Colleagues,
Sue Linder-Linsley, Executive Director and CEO of the Veterans Association Research Corporation in Dallas is interested in being part of a collaboration for several funding opportunities regarding veterans. Please review the list below to see if anyone at your institution may be interested in a specific project. You may respond directly to Sue or to me, either way. Thank you.
From: Linder-Linsley, Sue E. [mailto:Sue.Linder-Linsley at va.gov]
Sent: Tuesday, April 30, 2013 11:47 AM
To: Mason, Linda
Subject: FW: JUST RELEASED! FY13 DOD CDMRP Program Pre-Announcements
Linda:
It was great meeting you at the NCURA V meetings last week. I am willing to volunteer help with anything I can so keep me in mind.
I am following up to see if we can jump start a collaboration. Below are funding opportunities I forwarded to our researchers last week. Let me know if you have any researchers who may be interested in a join proposal and I will try to find someone on our side. I am open to the VA submitting as the prime but it would be great to be included as a sub /participant. I look forward to our first collaboration. These just happen to be DOD but we are interested in all funding sources.
Sue
Sue E. Linder-Linsley, MA
Executive Director and CEO
Dallas VA Research Corporation (DVARC)
4500 S. Lancaster Rd. Bldg 43, Suite 124 or PO Box 516
Dallas TX 75216-7167 Lancaster TX 75146-0516
214-857-0351
Sue.Linder-Linsley at va.gov<mailto:Sue.Linder-Linsley at va.gov>
www.dvarc.org<http://www.dvarc.org>
The Fiscal Year 2013 (FY13) Defense Appropriations Act provides research funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP).
This e-mail is to notify the research community of the recently released pre-announcements from the following programs:
Autism Research Program (ARP)
Bone Marrow Failure Research Program (BMFRP)
Duchenne Muscular Dystrophy Research Program (DMDRP)
Lung Cancer Research Program (OCRP)
Multiple Sclerosis Research Program (MSRP)
Ovarian Cancer Research Program (OCRP)
Peer Reviewed Medical Research Program (PRMRP)
Descriptions of each of the funding opportunities, eligibility, key mechanism elements, and funding can be found in the respective Program pre-announcement. FY13 pre-announcements can be found in the CDMRP home page features at http://cdmrp.army.mil.
----------------------------------------------------------------------
ARP at http://cdmrp.army.mil/pubs/press/2013/13arppreann.shtml
BMFRP at http://cdmrp.army.mil/pubs/press/2013/13bmfrppreann.shtml
DMDRP at http://cdmrp.army.mil/pubs/press/2013/13dmdrppreann.shtml
LCRP at http://cdmrp.army.mil/pubs/press/2013/13lcrppreann.shtml
MSRP at http://cdmrp.army.mil/pubs/press/2013/13msrppreann.shtml
OCRP at http://cdmrp.army.mil/pubs/press/2013/13ocrppreann.shtml
PRMRP at http://cdmrp.army.mil/pubs/press/2013/13prmrppreann.shtml
----------------------------------------------------------------------
Subsequent notifications will be sent when the program announcements/funding opportunities are released.
Please do not respond directly to this message. To be added or removed from this email list please send an email to help at cdmrp.org<mailto:help at cdmrp.org>.
The Fiscal Year 2013 (FY13) Defense Appropriations Act provides research funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP).
This e-mail is to notify the research community of the recently released pre-announcements from the following programs:
Amyotrophic Lateral Sclerosis Research Program (ALSRP)
Breast Cancer Research Program (BCRP)
Gulf War Illness Research Program (GWIRP)
Neurofibromatosis Research Program (NFRP)
Prostate Cancer Research Program (PCRP)
Tuberous Sclerosis Complex Research Program (TSCRP)
Descriptions of each of the funding opportunities, eligibility, key mechanism elements, and funding can be found in the respective Program pre-announcement. FY13 pre-announcements can be found in the CDMRP home page features at http://cdmrp.army.mil.
----------------------------------------------------------------------
ALSRP at http://cdmrp.army.mil/pubs/press/2013/13alsrppreann.shtml
BCRP at http://cdmrp.army.mil/pubs/press/2013/13bcrppreann.shtml
GWIRP at http://cdmrp.army.mil/pubs/press/2013/13gwirppreann.shtml
NFRP at http://cdmrp.army.mil/pubs/press/2013/13nfrppreann.shtml
PCRP at http://cdmrp.army.mil/pubs/press/2013/13pcrppreann.shtml
TSCRP at http://cdmrp.army.mil/pubs/press/2013/13tscrppreann.shtml
----------------------------------------------------------------------
Subsequent notifications will be sent when the program announcements/funding opportunities are released.
Please do not respond directly to this message. To be added or removed from this email list please send an email to help at cdmrp.org<mailto:help at cdmrp.org>.
NEWS RELEASE
Department of Defense Gulf War Illness Research Program
Anticipated Funding Opportunities for Fiscal Year 2013 (FY13)
The FY13 Defense Appropriations Act provides $20 million (M) to the Department of Defense Gulf War Illness Research Program (GWIRP) to support innovative, high-impact research into Gulf War Illness (GWI). The Department of Defense Gulf War Illness Research Program (GWIRP) is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).
The GWIRP is providing this information to allow investigators time to plan and develop applications. FY13 GWIRP program announcements and general application instructions for the following award mechanisms are anticipated to be posted on Grants.gov in May 2013. This pre-announcement should not be construed as an obligation by the government. Application submission dates are not available until the Program Announcements are released.
Investigator-Initiated Research Award
Independent investigators at all academic levels are eligible to apply.
* Supports new ideas in basic and clinical developmental research focusing on Gulf War Illness (GWI).
* Preliminary data are not required, and if provided, do not necessarily have to come from the GWI research field.
* Studies that provide outcomes clearly translatable to clinical use are encouraged.
* Clinical trials are not allowed under this mechanism.
The maximum allowable funding for the entire period of performance is $600,000 for direct costs.
The maximum period of performance is 3 years.
More cost-effective studies not requesting the full funding amount are encouraged.
Innovative Treatment Evaluation Award
Independent investigators at all academic levels are eligible to apply.
* Supports exploratory or small-scale studies evaluating potential treatments not previously studied in GWI.
* Pilot Phase II or Phase I/II trial combinations are permitted.
* Preliminary data are not required, though proposed studies must be supported by logical rationale.
* Studies with clear potential to move forward to Phase II/III clinical trials are encouraged
The maximum allowable funding for the entire period of performance is $450,000 for direct costs.
The maximum period of performance is 3 years.
More cost-effective studies not requesting the full funding amount are encouraged.
Clinical Trial Award
Independent investigators at all academic levels are eligible to apply.
* Supports larger, more definitive Phase II or III clinical trials focusing on treatments for GWI.
* Preliminary/preclinical data are required indicating potential substantial benefit for veterans with GWI.
* Pilot or exploratory studies focusing on treatments lacking preclinical/preliminary data should submit to the Innovative Treatment Evaluation Award (see above).
The maximum allowable funding for the entire period of performance is $1,500,000 for direct costs.
The maximum period of performance is 4 years.
More cost-effective studies not requesting the full funding amount are encouraged.
All applications must conform to the final program announcements and application instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
A pre-application is required and must be submitted through the CDMRP eReceipt website<http://cdmrp.org> (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government single-entry portal, Grants.gov<http://www.grants.gov>.
Submission deadlines are not available until the program announcements are released. Requests for email notification of the release of CDMRP program announcements may be sent to help at cdmrp.org<mailto:help at cdmrp.org>. For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website<http://cdmrp.army.mil> (http://cdmrp.army.mil).
If you are not the correct person or no longer wish to receive these types of announcements please let us know and we will update our distribution list.
Point of Contact:
CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs at mail.mil<mailto:usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs at mail.mil>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.onenet.net/pipermail/okgrantsmanship/attachments/20130604/ba64bbed/attachment-0001.html>
More information about the Okgrantsmanship
mailing list